Lexmark Healthcare Receives FDA 510(k) Class II Clearance for NilRead Enterprise Viewer LENEXA, Kan., July 8, 2015 (GLOBE NEWSWIRE) -- News Facts Lexmark (NYSE:LXK) announced today that it has received 510(k) Class II clearance from the U.S. Food and Drug Administration (FDA) for...